Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.6351
BATS BZX Real-Time Price
As of 1:52pm ET
 -0.0149 / -2.29%
Today’s Change
0.41
Today|||52-Week Range
2.24
-0.25%
Year-to-Date
MannKind Has a New Plan, but Will It Work?
Jan 18 / MotleyFool.com - Paid Partner Content
Is MannKind Corp. Ready to Rebound in 2017?
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.65
Today’s open0.65
Day’s range0.63 - 0.65
Volume29,941
Average volume (3 months)4,719,302
Market cap$310.9M
Dividend yield--
Data as of 1:52pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+113.19%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...-0.15-2.14%
SRNESorrento Therapeutic...+0.10+1.89%
NLNKNewLink Genetics Cor...+0.54+5.00%
CARACara Therapeutics In...-0.01-0.09%
Data as of 1:55pm ET, 01/20/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs